+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tocotrienol Market Size, Share & Trends Analysis Report By Product (Alpha, Beta, Gamma, and Delta), By End Use (Dietary Supplement, Pharmaceuticals, Cosmetics, and Others), By Regional Outlook and Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 193 Pages
  • February 2024
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5943366
Description Jump to:
The Global Tocotrienol Market size is expected to reach $530.6 million by 2030, rising at a market growth of 5.8% CAGR during the forecast period.

Tocotrienols are often included in dietary supplements to promote overall health and well-being. Consequently, the dietary supplements segment generate a 60.88% Share in the market by 2030. As demand for these supplements rises, so does the demand for tocotrienols as a key ingredient. Therefore, the rising demand for natural and functional ingredients is propelling the growth of the market.



Advanced extraction technologies enable manufacturers to extract tocotrienols from natural sources more efficiently. These technologies may involve innovative methods such as supercritical fluid extraction, molecular distillation, or chromatography, resulting in higher yields and lower production costs. In conclusion, ongoing advancements in extraction and formulation technologies drive the market’s growth.

Additionally, As people age, they become more susceptible to various health issues such as cardiovascular diseases, cognitive decline, and age-related macular degeneration. As potent antioxidants, tocotrienols have been studied for their potential role in supporting cardiovascular health. The aging population’s heightened awareness of these health concerns drives the demand for tocotrienol-rich supplements. Thus, the expansion of the global aging population is driving the market’s growth.

However, Tocotrienols are a form of vitamin E found in certain natural sources like palm oil and rice bran. Extracting tocotrienols from these sources involves a complex process that requires specific equipment and expertise. The cost of acquiring and maintaining this equipment contributes to the high cost of production. Furthermore, the yield of tocotrienols from natural sources may be relatively low compared to other products. In conclusion, the high production cost is hampering the market’s growth.

However, Restrictions on movement, border closures, and lockdown measures in various countries disrupted transportation and logistics networks, leading to delays in procuring raw materials and production inputs for tocotrienol manufacturers. Thus, the COVID-19 pandemic had a negative impact on the market.

By End-Use Analysis

On the basis of end-use, the market is segmented into dietary supplements, pharmaceuticals, cosmetics, and others. The dietary supplements segment acquired 62.8% revenue share in the market in 2022. Rich in antioxidants, tocotrienols aid in the body’s reduction of oxidative stress by scavenging dangerous free radicals. Given the prevalence of oxidative damage contributing to various chronic diseases and aging processes, consumers increasingly turn to dietary supplements containing tocotrienols to enhance their antioxidant defenses and protect against cellular damage.



By Product Analysis

Based on product, the market is divided into alpha, beta, gamma, and delta. The gamma segment acquired 24.5% revenue share in the market in 2022. Gamma-tocotrienol has shown promising neuroprotective effects in preclinical studies. It has been demonstrated to efficiently pass the blood-brain barrier and shield brain tissue from oxidative stress, potentially delaying or preventing the onset of neurodegenerative illnesses like Parkinson’s and Alzheimer’s.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region generated a 19.65% revenue share in the market in 2022. Manufacturers and retailers in the Asia Pacific region increasingly incorporate tocotrienols into a wide range of products, including dietary supplements, functional foods, cosmetics, and personal care products. Product innovation, coupled with effective marketing strategies highlighting the health and beauty benefits of tocotrienols, drives consumer awareness and demand for these products in the region.

List of Key Companies Profiled

  • Parchem Fine and Specialty Chemicals, Inc.
  • BASF SE
  • Eisai Co., Ltd.
  • Cayman Chemical Company, Inc.
  • Excelvite SDN. BHD.
  • BTSA BIOTECNOLOGÍAS APLICADAS S.L.
  • American River Nutrition, LLC
  • Vance Group Ltd.
  • Kuala Lumpur Kepong Berhad (Davos Life Science)
  • SourceOne Global Partners

Market Report Segmentation

By Product
  • Alpha
  • Beta
  • Gamma
  • Delta
By End Use
  • Dietary Supplements
  • Pharmaceuticals
  • Cosmetics
  • Others
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Tocotrienol Market, by Product
1.4.2 Global Tocotrienol Market, by End Use
1.4.3 Global Tocotrienol Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Global Tocotrienol Market, by Product
4.1 Global Alpha Market, by Region
4.2 Global Beta Market, by Region
4.3 Global Gamma Market, by Region
4.4 Global Delta Market, by Region
Chapter 5. Global Tocotrienol Market, by End-use
5.1 Global Dietary Supplements Market, by Region
5.2 Global Pharmaceuticals Market, by Region
5.3 Global Cosmetics Market, by Region
5.4 Global Others Market, by Region
Chapter 6. Global Tocotrienol Market, by Region
6.1 North America Tocotrienol Market
6.1.1 North America Tocotrienol Market, by Product
6.1.1.1 North America Alpha Market, by Country
6.1.1.2 North America Beta Market, by Country
6.1.1.3 North America Gamma Market, by Country
6.1.1.4 North America Delta Market, by Country
6.1.2 North America Tocotrienol Market, by End-use
6.1.2.1 North America Dietary Supplements Market, by Country
6.1.2.2 North America Pharmaceuticals Market, by Country
6.1.2.3 North America Cosmetics Market, by Country
6.1.2.4 North America Others Market, by Country
6.1.3 North America Tocotrienol Market, by Country
6.1.3.1 US Tocotrienol Market
6.1.3.1.1 US Tocotrienol Market, by Product
6.1.3.1.2 US Tocotrienol Market, by End-use
6.1.3.2 Canada Tocotrienol Market
6.1.3.2.1 Canada Tocotrienol Market, by Product
6.1.3.2.2 Canada Tocotrienol Market, by End-use
6.1.3.3 Mexico Tocotrienol Market
6.1.3.3.1 Mexico Tocotrienol Market, by Product
6.1.3.3.2 Mexico Tocotrienol Market, by End-use
6.1.3.4 Rest of North America Tocotrienol Market
6.1.3.4.1 Rest of North America Tocotrienol Market, by Product
6.1.3.4.2 Rest of North America Tocotrienol Market, by End-use
6.2 Europe Tocotrienol Market
6.2.1 Europe Tocotrienol Market, by Product
6.2.1.1 Europe Alpha Market, by Country
6.2.1.2 Europe Beta Market, by Country
6.2.1.3 Europe Gamma Market, by Country
6.2.1.4 Europe Delta Market, by Country
6.2.2 Europe Tocotrienol Market, by End-use
6.2.2.1 Europe Dietary Supplements Market, by Country
6.2.2.2 Europe Pharmaceuticals Market, by Country
6.2.2.3 Europe Cosmetics Market, by Country
6.2.2.4 Europe Others Market, by Country
6.2.3 Europe Tocotrienol Market, by Country
6.2.3.1 Germany Tocotrienol Market
6.2.3.1.1 Germany Tocotrienol Market, by Product
6.2.3.1.2 Germany Tocotrienol Market, by End-use
6.2.3.2 UK Tocotrienol Market
6.2.3.2.1 UK Tocotrienol Market, by Product
6.2.3.2.2 UK Tocotrienol Market, by End-use
6.2.3.3 France Tocotrienol Market
6.2.3.3.1 France Tocotrienol Market, by Product
6.2.3.3.2 France Tocotrienol Market, by End-use
6.2.3.4 Russia Tocotrienol Market
6.2.3.4.1 Russia Tocotrienol Market, by Product
6.2.3.4.2 Russia Tocotrienol Market, by End-use
6.2.3.5 Spain Tocotrienol Market
6.2.3.5.1 Spain Tocotrienol Market, by Product
6.2.3.5.2 Spain Tocotrienol Market, by End-use
6.2.3.6 Italy Tocotrienol Market
6.2.3.6.1 Italy Tocotrienol Market, by Product
6.2.3.6.2 Italy Tocotrienol Market, by End-use
6.2.3.7 Rest of Europe Tocotrienol Market
6.2.3.7.1 Rest of Europe Tocotrienol Market, by Product
6.2.3.7.2 Rest of Europe Tocotrienol Market, by End-use
6.3 Asia Pacific Tocotrienol Market
6.3.1 Asia Pacific Tocotrienol Market, by Product
6.3.1.1 Asia Pacific Alpha Market, by Country
6.3.1.2 Asia Pacific Beta Market, by Country
6.3.1.3 Asia Pacific Gamma Market, by Country
6.3.1.4 Asia Pacific Delta Market, by Country
6.3.2 Asia Pacific Tocotrienol Market, by End-use
6.3.2.1 Asia Pacific Dietary Supplements Market, by Country
6.3.2.2 Asia Pacific Pharmaceuticals Market, by Country
6.3.2.3 Asia Pacific Cosmetics Market, by Country
6.3.2.4 Asia Pacific Others Market, by Country
6.3.3 Asia Pacific Tocotrienol Market, by Country
6.3.3.1 China Tocotrienol Market
6.3.3.1.1 China Tocotrienol Market, by Product
6.3.3.1.2 China Tocotrienol Market, by End-use
6.3.3.2 Japan Tocotrienol Market
6.3.3.2.1 Japan Tocotrienol Market, by Product
6.3.3.2.2 Japan Tocotrienol Market, by End-use
6.3.3.3 India Tocotrienol Market
6.3.3.3.1 India Tocotrienol Market, by Product
6.3.3.3.2 India Tocotrienol Market, by End-use
6.3.3.4 South Korea Tocotrienol Market
6.3.3.4.1 South Korea Tocotrienol Market, by Product
6.3.3.4.2 South Korea Tocotrienol Market, by End-use
6.3.3.5 Singapore Tocotrienol Market
6.3.3.5.1 Singapore Tocotrienol Market, by Product
6.3.3.5.2 Singapore Tocotrienol Market, by End-use
6.3.3.6 Malaysia Tocotrienol Market
6.3.3.6.1 Malaysia Tocotrienol Market, by Product
6.3.3.6.2 Malaysia Tocotrienol Market, by End-use
6.3.3.7 Rest of Asia Pacific Tocotrienol Market
6.3.3.7.1 Rest of Asia Pacific Tocotrienol Market, by Product
6.3.3.7.2 Rest of Asia Pacific Tocotrienol Market, by End-use
6.4 LAMEA Tocotrienol Market
6.4.1 LAMEA Tocotrienol Market, by Product
6.4.1.1 LAMEA Alpha Market, by Country
6.4.1.2 LAMEA Beta Market, by Country
6.4.1.3 LAMEA Gamma Market, by Country
6.4.1.4 LAMEA Delta Market, by Country
6.4.2 LAMEA Tocotrienol Market, by End-use
6.4.2.1 LAMEA Dietary Supplements Market, by Country
6.4.2.2 LAMEA Pharmaceuticals Market, by Country
6.4.2.3 LAMEA Cosmetics Market, by Country
6.4.2.4 LAMEA Others Market, by Country
6.4.3 LAMEA Tocotrienol Market, by Country
6.4.3.1 Brazil Tocotrienol Market
6.4.3.1.1 Brazil Tocotrienol Market, by Product
6.4.3.1.2 Brazil Tocotrienol Market, by End-use
6.4.3.2 Argentina Tocotrienol Market
6.4.3.2.1 Argentina Tocotrienol Market, by Product
6.4.3.2.2 Argentina Tocotrienol Market, by End-use
6.4.3.3 UAE Tocotrienol Market
6.4.3.3.1 UAE Tocotrienol Market, by Product
6.4.3.3.2 UAE Tocotrienol Market, by End-use
6.4.3.4 Saudi Arabia Tocotrienol Market
6.4.3.4.1 Saudi Arabia Tocotrienol Market, by Product
6.4.3.4.2 Saudi Arabia Tocotrienol Market, by End-use
6.4.3.5 South Africa Tocotrienol Market
6.4.3.5.1 South Africa Tocotrienol Market, by Product
6.4.3.5.2 South Africa Tocotrienol Market, by End-use
6.4.3.6 Nigeria Tocotrienol Market
6.4.3.6.1 Nigeria Tocotrienol Market, by Product
6.4.3.6.2 Nigeria Tocotrienol Market, by End-use
6.4.3.7 Rest of LAMEA Tocotrienol Market
6.4.3.7.1 Rest of LAMEA Tocotrienol Market, by Product
6.4.3.7.2 Rest of LAMEA Tocotrienol Market, by End-use
Chapter 7. Company Profiles
7.1 Parchem Fine and Specialty Chemicals, Inc.
7.1.1 Company Overview
7.1.2 SWOT Analysis
7.2 BASF SE
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Eisai Co., Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 SWOT Analysis
7.4 Cayman Chemical Company, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Acquisition and Mergers:
7.4.3 SWOT Analysis
7.5 Excelvite SDN. BHD.
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 BTSA BIOTECNOLOGÍAS APLICADAS S.L.
7.6.1 Company Overview
7.7 American River Nutrition, LLC
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 Vance Group Ltd.
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Kuala Lumpur Kepong Berhad (Davos Life Science)
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.9.6 SWOT Analysis
7.10. SourceOne Global Partners
7.10.1 Company Overview
7.10.2 SWOT Analysis
Chapter 8. Winning Imperatives of Tocotrienol Market

Companies Mentioned

  • Parchem Fine and Specialty Chemicals, Inc.
  • BASF SE
  • Eisai Co., Ltd.
  • Cayman Chemical Company, Inc.
  • Excelvite SDN. BHD.
  • BTSA BIOTECNOLOGÍAS APLICADAS S.L.
  • American River Nutrition, LLC
  • Vance Group Ltd.
  • Kuala Lumpur Kepong Berhad (Davos Life Science)
  • SourceOne Global Partners

Methodology

Loading
LOADING...

Related Topics

Related Reports

Tocotrienol Market Size, Share & Trends Analysis Report by Product (Alpha, Beta, Gamma, Delta), End-use (Dietary Supplements, Pharmaceuticals, Cosmetics, Others), Region, and Segment Forecasts, 2024-2030 - Product Image

Tocotrienol Market Size, Share & Trends Analysis Report by Product (Alpha, Beta, Gamma, Delta), End-use (Dietary Supplements, Pharmaceuticals, Cosmetics, Others), Region, and Segment Forecasts, 2024-2030

  • Report
  • 125 Pages
  • Global
From
Tocotrienol Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031 - Product Image

Tocotrienol Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031

  • Report
  • 144 Pages
  • Global
From
Sterols - Global Strategic Business Report - Product Image

Sterols - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Fatty Acid Supplements - Global Strategic Business Report - Product Image

Fatty Acid Supplements - Global Strategic Business Report

  • Report
  • 311 Pages
  • Global
From
Beta-Eudesmol Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Beta-Eudesmol Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.